7
Articles Count
8396
Viewing Count
Sarina Yang

Like to focus on Medicare and innovative medicines

Newsoara licenses oncolytic virus from Genelux in ...
Sarina Yang · 22 days ago
Genelux will receive $11 million upfront and up to $160 million in milestone payments, as well as tiered royalties sales.
Further information
News
Anji Pharma closes $70M Series B to support two dr...
Sarina Yang · 22 days ago
The fund will also be used to incubate cancer pipelines.
Further information
News
Virogin bags $120M Series D+ to support the develo...
Sarina Yang · 24 days ago
The Series D+ round was led by China Life Equity Investment, followed by Shenzhen Capital Group, China Securities Investment and GF Qianhe.
Further information
News
Eli Lilly report positive phase III data of Ramuci...
Sarina Yang · 24 days ago
The data showed the survival benefit consistent with the global pivotal registration clinical trial and well-tolerated.
Further information
News
Edding announced positive phase III results from S...
Sarina Yang · 24 days ago
The trial was a multi-center, randomized, double-blind, placebo-controlled phase III clinical study to assess the efficacy and safety of Lusutrombopag for the treatment of thrombocytopenia in chronic liver disease (CLD) patients who are scheduled to undergo elective invasive procedures in the Chinese population.
Further information
News
Psoriasis’ drug Taltz seeking the new market appr...
Sarina Yang · 27 days ago
axSpA is a chronic autoimmune diseases Ixekizumab is an inhibitor targeting interleukin 17A (IL-17A) that selectively binds IL-17A and inhibits its interaction with the IL-17 receptor.
Further information
News
Everest partners with AbCellera to gain antibodies...
Sarina Yang · 28 days ago
​Everest Medicines and AbCellera entered a multi-year collaboration to discover therapeutic antibodies for up to 10 targets selected by Everest. This is the third deal Everest disclosed in two weeks.
Further information
News

Personal Information

Copyright © 2016-2021 PharmaDJ .All Rights Reserved.   Suggestions and feedback: Support@PharmaDJ.com   Record/License No.:沪ICP备17054709号-1  
About PharmaDJ | Subscription | Contact Us | Copyright Statement